The Efficacy of Leukotriene Inhibitor in Adult Patients With Moderate SARS-COV-2 Symptoms (COVID19)

NCT04871828 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Moderate Covid19

Interventions

DRUG: Leukotriene Receptor Antagonist
OTHER: Placebo

Sponsor

King Abdullah International Medical Research Center